Cargando…

Managed Care Perspective on Three New Agents for Type 2 Diabetes

BACKGROUND: Despite effective monotherapy for diabetes, approximately 50% of patients require additional medications after 3 years to achieve target glycosylated hemoglobin (A1C) less than 7%. Three new agents, each the first in its therapeutic class with a unique mechanism of action, have been appr...

Descripción completa

Detalles Bibliográficos
Autores principales: VanDeKoppel, Shawna, Choe, Hae Mi, Sweet, Burgunda V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438140/
https://www.ncbi.nlm.nih.gov/pubmed/18500914
http://dx.doi.org/10.18553/jmcp.2008.14.4.363

Ejemplares similares